MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis

Kidney International

Volumn 56, Issue 1, 1999, Pages 261-267

  Guasch, Antonio ^a   Zayas, Carlos F ^a   Badr, Kamal F ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Dextran sieving; Glomerular inflammation; Leukotrienes; Transglomerular protein trafficking

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 (2 QUINOLINYLMETHOXY) 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ALBUMIN; COMPLEMENT COMPONENT C1Q; DEXTRAN; IMMUNOGLOBULIN G; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT DEFICIENCY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG STRUCTURE; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY PLASMA FLOW; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; ORAL DRUG ADMINISTRATION; PILOT STUDY; PRIORITY JOURNAL; PROTEINURIA;

EID: 0033000883     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00537.x     Document Type: Article

References (11)

1. ANONYMOUS: Incidence and prevalence of ESRD. USRDS. United States Renal Data System. Am J Kidney Dis 30:S40-S53, 1997
2. GOURLEY MF, AUSTIN HA III, SCOTT D, YARBORO CH, VAUGHAN EM, MUIR J, BOUMPAS DT, KLIPPEL JH, BALOW JE, STEINBERG AD: Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis: A randomized, controlled trial. Ann Intern Med 125:549-557, 1996
3. DONADIO JV JR, GLASSOCK RJ: Immunosuppressive drug therapy in lupus nephritis. Am J Kidney Dis 21:239-250, 1993
4. BOUMPAS DT, AUSTIN HA III, VAUGHAN EM, YARBORO CH, KLIPPEL JH, BALOW JE: Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366-369, 1993
5. ABBATE M, REMUZZI G: Glomerulonephritis: From new knowledge on the mechanisms of tissue damage to novel therapies. Curr Opin Nephrol Hypertens 4:374-382, 1995
6. CATTELL V: Macrophages in acute glomerular inflammation. Kidney Int 45:945-952, 1994
7. TAKAHASHI K, BADR KF: Lipoxygenase products as mediators in immune-mediated glomerular injury. Semin Nephrol 13:129-136, 1993
8. SPURNEY RF, RUIZ P, PISETSKY DS, COFFMAN TM: Enhanced renal leukotriene production in murine lupus: Role of lipoxygenase metabolites. Kidney Int 39:95-102, 1991
9. WILSON CB: Renal response to immunological injury, in The Kidney, edited by BRENNER BM, Philadelphia, W.B. Saunders, 1996, p 1253
10. BADR KF, SCHREINER GF, WASSERMAN M, ICHIKAWA I: Preservation of the glomerular capillary ultrafiltration coefficient during rat nephrotoxic serum nephritis by a specific leukotriene D4 receptor antagonist. J Clin Invest 81:1702-1709, 1988
11. SCHREINER GF, ROVIN B, LEFKOWITH JB: The antiinflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis:The modulation of macrophage migration and eicosanoid metabolism. J Immunol 143:3192-3199, 1989